73/100BDanaher stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Danaher is 238.77, 3.2% above the current price of 231.42. Their targets range from 195.00 to 275.00.
Of the 16 firms that rated Danaher in the past 12 months, 14 rate it buy or strong buy, 2 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 195.00 to 275.00, with an average of 238.77.
| Buy | 14 | |
| Hold | 2 | |
| Sell | 0 |
12-month price target
| Highest target | 275.00 |
| Average target | 238.77 |
| Lowest target | 195.00 |
| Current price | 231.42 |
Danaher price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Danaher price target and rating?
How analysts rate Danaher, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
14 of 16 firms rate it buy now, against 14 of 17 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Danaher analyst upgrades, downgrades and price targets
The latest rating change came on 27 May 2026, when Citigroup downgraded Danaher from Buy to Neutral. The most recent new target came from UBS on 22 October 2026: 260.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 22 Oct 2026 | UBS Douglas Schenkel | — | 250.00 → 260.00 | +4.0% | 233.57 |
| 22 Oct 2026 | Goldman Sachs | — | 265.00 → 275.00 | +3.8% | 234.09 |
| 22 Oct 2026 | Robert W. Baird | — | 249.00 → 254.00 | +2.0% | 234.09 |
| 22 Oct 2026 | Barclays | Reiterated · Overweight | 230.00 → 260.00 | +13.0% | 234.09 |
| 12 Oct 2026 | Morgan Stanley Kallum Titchmarsh | — | 270.00 → 240.00 | -11.1% | 220.24 |
| 5 Oct 2026 | RBC Capital Dan Leonard | Reiterated · Outperform | 215.00 → 250.00 | +16.3% | 214.06 |
| 1 Oct 2026 | Guggenheim Subbu Nambi | Reiterated · Buy | 200.00 → 250.00 | +25.0% | 220.34 |
| 9 Sept 2026 | UBS Douglas Schenkel | — | 250.00 | — | 205.20 |
| 22 Jul 2026 | Deutsche Bank Justin Bowers | — | 240.00 | — | 175.03 |
| 22 Jul 2026 | RBC Capital | Reiterated · Outperform | 200.00 → 215.00 | +7.5% | 179.14 |
| 22 Jul 2026 | Stifel Nicolaus Daniel Arias | Reiterated · Buy | 220.00 | — | 179.14 |
| 22 Jul 2026 | Guggenheim | Reiterated · Buy | 200.00 | — | 179.14 |
| 22 Jul 2026 | Wells Fargo | Reiterated · Equal Weight | 240.00 → 195.00 | -18.8% | 179.14 |
| 6 Jul 2026 | Evercore ISI Vijay Kumar | Reiterated · Outperform | 254.00 → 230.00 | -9.4% | 190.60 |
| 11 Jun 2026 | Piper Sandler | Reiterated · Neutral | 200.00 | — | 183.63 |
| 3 Jun 2026 | HSBC | Reiterated · Buy | 230.00 | — | 176.11 |
| 27 May 2026 | Citigroup | Downgraded · Buy → Neutral | — | — | — |
| 14 May 2026 | RBC Capital | — | 241.00 → 200.00 | -17.0% | 164.54 |
| 21 Apr 2026 | Jefferies Tycho Peterson | — | 265.00 → 245.00 | -7.5% | 194.45 |
| 17 Apr 2026 | Robert W. Baird Catherine Ramsey Schulte | — | 251.00 → 249.00 | -0.8% | 193.78 |
| 17 Apr 2026 | Redburn Partners | — | 220.00 → 205.00 | -6.8% | 193.78 |
| 14 Apr 2026 | Barclays | Reiterated · Overweight | 230.00 | — | 195.87 |
| 29 Jan 2026 | Robert W. Baird | — | 247.00 → 251.00 | +1.6% | 224.54 |
| 28 Jan 2026 | Jefferies | — | 265.00 | — | 224.54 |
| 28 Jan 2026 | Evercore ISI Vijay Kumar | — | 250.00 → 254.00 | +1.6% | 224.48 |
| 14 Jan 2026 | Argus Research | — | 265.00 | — | 235.56 |
| 5 Jan 2026 | Evercore ISI Vijay Kumar | — | 250.00 | — | 231.72 |
| 15 Dec 2025 | Wells Fargo | Reiterated · Equal Weight | 230.00 → 240.00 | +4.3% | 226.71 |
| 9 Dec 2025 | Goldman Sachs | — | 240.00 → 265.00 | +10.4% | 224.48 |
| 1 Dec 2025 | Morgan Stanley | — | 270.00 | — | 224.14 |
Danaher EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Danaher's EPS to grow 26.6% a year until 2028. Over the last 5 years it grew 0.6% a year, and over the last 3 years it fell 19.4%.
Analysts expect Danaher's revenue to grow 7.0% a year until 2028. Over the last 5 years it grew 2.0% a year, and over the last 3 years it fell 2.7%.
Revenue
EPS
Does Danaher beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 8.3% off the result, either way, and their revenue estimate 6.0%, over the last 12 quarters.
- EPS beats
- 100 / 136
- Revenue beats
- 90 / 118
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +8.3%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 21 Oct 2026 | 1.92 | 2.11 | +9.9% | 6.56B | 6.55B | -0.1% |
| Q2 FY2026 | 21 Jul 2026 | 1.85 | 1.94 | +4.9% | 6.12B | 6.27B | +2.4% |
| Q1 FY2026 | 21 Apr 2026 | 1.94 | 2.06 | +6.2% | 5.98B | 5.95B | -0.5% |
| Q4 FY2025 | 28 Jan 2026 | 2.16 | 2.23 | +3.2% | 6.81B | 6.84B | +0.4% |
| Q3 FY2025 | 21 Oct 2025 | 1.72 | 1.89 | +9.9% | 6.00B | 6.05B | +0.9% |
| Q2 FY2025 | 22 Jul 2025 | 1.64 | 1.80 | +9.8% | 5.84B | 5.94B | +1.7% |
| Q1 FY2025 | 22 Apr 2025 | 1.63 | 1.88 | +15.3% | 5.57B | 5.74B | +3.0% |
| Q4 FY2024 | 29 Jan 2025 | 2.14 | 2.14 | 0.0% | 6.45B | 6.54B | +1.4% |
| Q3 FY2024 | 22 Oct 2024 | 1.57 | 1.71 | +8.9% | 5.59B | 5.80B | +3.8% |
| Q2 FY2024 | 23 Jul 2024 | 1.57 | 1.72 | +9.6% | 5.59B | 5.74B | +2.8% |
| Q1 FY2024 | 23 Apr 2024 | 1.72 | 1.92 | +11.6% | 5.62B | 5.80B | +3.1% |
| Q4 FY2023 | 30 Jan 2024 | 1.90 | 2.09 | +10.0% | 5.59B | 2.69B | -51.9% |
Danaher stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Danaher's earnings keep growing at the 9.5% a year analysts expect to FY2028, it would earn about 12.27 a share in FY2030. At the P/E it has traded at over the last five years (24.0 to 45.2) that is 294.67 to 554.20 a share, or 448.45 at its average P/E of 36.5. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 8.59 | 206.15 | 313.74 | 387.73 |
| FY2027 | 9.31 | 223.57 | 340.25 | 420.49 |
| FY2028 | 10.24 | 245.80 | 374.07 | 462.28 |
| FY2029 (extrapolated) | 11.21 | 269.12 | 409.58 | 506.16 |
| FY2030 (extrapolated) | 12.27 | 294.67 | 448.45 | 554.20 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 9.5% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (24.0, 36.5, 45.2).
Is Danaher stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Danaher's P/E of 37.8 is around the middle of its 5-year range (23.1 to 51.5, median 36.7). It is in line with its own history. Buyers pay less for each point of growth than usual: a PEG of 1.4 on expected growth against 60.6 on its median P/E and past five years' growth. Growing 26.6% a year, Danaher earns a P/E of 25.0 at a PEG of 1 (at most 25): × the next twelve months' EPS of 9.22, a fair value of 230.43, close to the price of 231.42. Its forward P/E, on the consensus for FY2026, is 26.9.
Fair value on growth is a P/E equal to the EPS growth analysts expect a year (a PEG of 1, at most 25) times the earnings per share of the next twelve months; the ends of the bar are a PEG of 0.75 and 1.25 (a P/E of 18.8 and 31.3). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 37.81
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 36.71
- Five-year P/E range
- 23.1 – 51.5
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 26.95
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 3.98
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +3.2%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 235.690 | 464.49205Price 235.69627 | +97.1% | |
| 28.860 | 56.2634Price 28.8696 | +94.9% | |
| 199.110 | 384.58163Price 199.112,644 | +93.1% | |
| 123.990 | 237.24178Price 123.99297 | +91.3% | |
| 157.820 | 297.58169Price 157.82471 | +88.6% | |
| 162.670 | 305.52160Price 162.67396 | +87.8% | |
| 216.610 | 405.38304Price 216.61507 | +87.1% |
Furthest below the fair value on each stock's page, updated every day.